BioSyent Releases Financial Results for First Quarter 2026

CA · 2026-05-14 · Montreal Gazette

MISSISSAUGA, Ontario, May 14, 2026 (GLOBE NEWSWIRE) — BioSyent Inc. (“BioSyent”, TSX Venture: RX) released today its financial results for the first quarter (Q1) ended March 31, 2026. Key highlights include: (CAD) Q1 2026 % Change vs.Q1 2025 TTMMar 31, 2026 % Change vs.TTMMar 31, 2025 Pharmaceutical Sales 10,803,107 +1% 40,987,981 +11% Oral Health Sales... The post BioSyent Releases Financial Results for First Quarter 2026 appeared first on Montreal Gazette .

Original source: Montreal Gazette